伊之密最新一期业绩显示，截至2025一季报，公司营业总收入11.87亿元、同比增长24.32%，归属净利 润1.32亿元，同比增长14.29%，扣非净利润1.26亿元，同比增长13.57%，流动比率1.610、速动比率 0.981、资产负债率57.10%。 金融界消息 截至2025年7月29日收盘，伊之密（300415）报收于21.12元，下跌0.09%，换手率1.47%， 成交量6.64万手，成交金额1.39亿元。 来源：金融界 资金流向方面，今日主力资金净流出2759.08万元，占比成交额19.8%。其中，超大单净流出1451.26万 元、占成交额10.42%，大单净流出1307.82万元、占成交额9.39%，中单净流出流入968.22万元、占成交 额6.95%，小单净流入1790.87万元、占成交额12.85%。 天眼查商业履历信息显示，伊之密股份有限公司，成立于2004年，位于佛山市，是一家以从事橡胶和塑 料制品业为主的企业。企业注册资本46856.2084万人民币，实缴资本8100万人民币。公司法定代表人为 甄荣辉。 通过天眼查大数据分析，伊之密股份有限公司共对外投资了17家企业，参与招投标项目99 ...

证券代码：601966 证券简称：玲珑轮胎 公告编号：2025-053 山东玲珑轮胎股份有限公司 关于控股股东增持公司股份的进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 已披露增持计划情况：基于对山东玲珑轮胎股份有限公司（以下简称"公司"） 未来发展的信心和价值的认可，以及为维护股价稳定和股东利益，公司控股股东 玲珑集团有限公司（以下简称"玲珑集团"）计划自 2025 年 5 月 7 日起（含当日） 易所交易系统增持公司股份，累计增持金额不低于人民币 2 亿元不超过人民币 3 亿元。本次增持计划不设定价格区间，将根据公司股票价格波动情况及资本市场 整体趋势，择机逐步实施增持计划。 ? 增持计划的实施进展情况：2025 年 5 月 7 日至 7 月 29 日期间，玲珑集团以 自有资金和自筹资金（包含股票增持专项再贷款）通过上海证券交易所集中竞价 方式增持公司 6,738,033 股 A 股股份，占公司总股本的比例约 0.46%，累计增持 金额约 1 亿元，增持金额已达到区间下限的 50% ...

金融界消息 截至2025年7月29日收盘，富岭股份（001356）报收于15.07元，下跌1.12%，换手率 6.92%，成交量8.67万手，成交金额1.30亿元。 资金流向方面，今日主力资金净流出1857.38万元，占比成交额14.23%。其中，超大单净流出1023.48万 元、占成交额7.84%，大单净流出833.90万元、占成交额6.39%，中单净流出流入619.35万元、占成交额 4.75%，小单净流入1238.03万元、占成交额9.49%。 富岭股份最新一期业绩显示，截至2025一季报，公司营业总收入5.34亿元、同比减少0.20%，归属净利 润3497.77万元，同比减少34.85%，扣非净利润3494.87万元，同比减少34.46%，流动比率4.112、速动比 率2.855、资产负债率19.37%。 天眼查商业履历信息显示，富岭科技股份有限公司，成立于1992年，位于台州市，是一家以从事橡胶和 塑料制品业为主的企业。企业注册资本58932万人民币，实缴资本44199万人民币。公司法定代表人为江 桂兰。 通过天眼查大数据分析，富岭科技股份有限公司共对外投资了7家企业，参与招投标项目8次，知识产权 ...

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Meihao Medical (301363), indicating a slight decline in stock price and a mixed financial outlook for the first quarter of 2025 [1][3] - As of July 29, 2025, Meihao Medical's stock closed at 19.0 yuan, down 0.89%, with a turnover rate of 4.85% and a trading volume of 75,700 hands, amounting to a transaction value of 143 million yuan [1] - The company experienced a net outflow of main funds amounting to 13.99 million yuan, representing 9.78% of the transaction value, with significant outflows from large and medium orders [1] Group 2 - For the first quarter of 2025, Meihao Medical reported total operating revenue of 296 million yuan, reflecting a year-on-year growth of 5.05%, while net profit attributable to shareholders decreased by 10.62% to 51.88 million yuan [1] - The company's financial ratios indicate a current ratio of 5.964, a quick ratio of 5.060, and a debt-to-asset ratio of 12.08%, suggesting a strong liquidity position [1] - Meihao Medical, established in 2010 and based in Shenzhen, has a registered capital of 406.66 million yuan and a paid-in capital of 321.16 million yuan [1][2]

横河精密（300539）公告，公司股票交易价格连续七个交易日(2025年7月21日至2025年7月29日)收盘价 格涨幅偏离值累计超过100%，属于股票交易严重异常波动的情况。公司关注到近期市场对于人形机器 人相关概念的关注度较高，公司减速器类产品主要应用于智能家电和汽车零部件领域，整体营收相对占 比不高，未涉及人形机器人业务。 ...

来源：金融界 资金流向方面，今日主力资金净流入1700.10万元，占比成交额3.65%。其中，超大单净流入1281.23万 元、占成交额2.75%，大单净流入418.87万元、占成交额0.9%，中单净流出流入207.06万元、占成交额 0.44%，小单净流出1907.16万元、占成交额4.09%。 天秦装备最新一期业绩显示，截至2025一季报，公司营业总收入4987.34万元、同比增长29.46%，归属 净利润924.25万元，同比减少7.60%，扣非净利润912.25万元，同比减少8.60%，流动比率4.819、速动比 率4.556、资产负债率13.35%。 天眼查商业履历信息显示，秦皇岛天秦装备制造股份有限公司，成立于1996年，位于秦皇岛市，是一家 以从事橡胶和塑料制品业为主的企业。企业注册资本15858.236万人民币，实缴资本5439.83万人民币。 公司法定代表人为宋金锁。 通过天眼查大数据分析，秦皇岛天秦装备制造股份有限公司共对外投资了9家企业，参与招投标项目35 次，知识产权方面有商标信息33条，专利信息62条，此外企业还拥有行政许可26个。 金融界消息 截至2025年7月29日收盘，天秦装备 ...

金融界消息 截至2025年7月29日收盘，通达创智（001368）报收于25.28元，上涨1.36%，换手率 24.65%，成交量7.91万手，成交金额1.99亿元。 天眼查商业履历信息显示，通达创智(厦门)股份有限公司，成立于2016年，位于厦门市，是一家以从事 橡胶和塑料制品业为主的企业。企业注册资本11417.46万人民币，实缴资本11417.46万人民币。公司法 定代表人为王亚华。 通过天眼查大数据分析，通达创智(厦门)股份有限公司共对外投资了3家企业，参与招投标项目24次， 知识产权方面有商标信息3条，专利信息152条，此外企业还拥有行政许可25个。 来源：金融界 资金流向方面，今日主力资金净流入2124.76万元，占比成交额10.66%。其中，超大单净流入543.26万 元、占成交额2.73%，大单净流入1581.50万元、占成交额7.93%，中单净流出流入712.76万元、占成交 额3.58%，小单净流出2837.52万元、占成交额14.24%。 通达创智最新一期业绩显示，截至2025一季报，公司营业总收入2.68亿元、同比增长13.47%，归属净利 润2815.47万元，同比减少10.82%， ...

金融界消息 截至2025年7月29日收盘，国恩股份（002768）报收于37.23元，上涨1.06%，换手率 3.71%，成交量6.56万手，成交金额2.42亿元。 资金流向方面，今日主力资金净流入2010.16万元，占比成交额8.29%。其中，超大单净流入197.06万 元、占成交额0.81%，大单净流入1813.10万元、占成交额7.48%，中单净流出流出203.69万元、占成交 额0.84%，小单净流出1806.47万元、占成交额7.45%。 国恩股份最新一期业绩显示，截至2025一季报，公司营业总收入44.12亿元、同比减少0.23%，归属净利 润1.11亿元，同比减少9.79%，扣非净利润1.02亿元，同比减少16.78%，流动比率1.521、速动比率 1.043、资产负债率62.55%。 天眼查商业履历信息显示，青岛国恩科技股份有限公司，成立于2000年，位于青岛市，是一家以从事橡 胶和塑料制品业为主的企业。企业注册资本27125万人民币，实缴资本27125万人民币。公司法定代表人 为王爱国。 通过天眼查大数据分析，青岛国恩科技股份有限公司共对外投资了22家企业，参与招投标项目43次，知 识产权方 ...

Group 1 - The core viewpoint of the news is that Enjie Co., Ltd. (002812) has shown a slight increase in stock price, with a closing price of 31.27 yuan, reflecting a 1.0% rise as of July 29, 2025 [1] - The company reported a total operating revenue of 2.729 billion yuan for the first quarter of 2025, representing a year-on-year growth of 17.23% [1] - The net profit attributable to shareholders for the same period was 25.9866 million yuan, which is a significant decrease of 83.57% year-on-year [1] Group 2 - Enjie Co., Ltd. has a current liquidity ratio of 1.051 and a quick ratio of 0.824, indicating its short-term financial health [1] - The company's debt-to-asset ratio stands at 44.79%, reflecting its leverage position [1] - The company has made investments in 10 external enterprises and has participated in 70 bidding projects, showcasing its active engagement in the market [2]

Core Viewpoint - Tian Tie Technology's controlling shareholder Wang Meiyu plans to reduce his stake in the company, which raises concerns about the company's financial health and future prospects as the stock price reaches new highs [1][15]. Group 1: Shareholder Actions - Wang Meiyu, the largest shareholder with a 7.55% stake, intends to reduce his holdings by up to 38.948 million shares, representing 3% of the total share capital [1]. - The stock price of Tian Tie Technology reached a year-high of 7.79 yuan per share, with a market capitalization exceeding 10 billion yuan, reflecting a 56% increase year-to-date [1]. Group 2: Financial Health - As of June 19, 2025, Wang Meiyu and five other concerted actors hold a total of 273 million shares, with 162 million shares pledged, resulting in a pledge ratio of 59.34% [2]. - The company has a significant external guarantee balance of 836 million yuan, which constitutes 34.66% of the audited net assets for 2024, indicating substantial financial risk [2]. - Operating cash flow has been negative for three consecutive years, with cumulative losses of 1.13 billion yuan from 2022 to 2024 [2]. Group 3: Business Performance - Tian Tie Technology's main business, which focuses on rail engineering rubber products, has seen a decline in revenue due to reduced infrastructure investment, with revenues dropping from 1.073 billion yuan in 2021 to 300 million yuan in 2023 [3]. - The lithium materials business, acquired through significant investments, has become a financial burden, with losses reported at 60.52 million yuan in 2024 and further losses in 2025 [6][7]. Group 4: Profitability and Cash Flow - In 2024, Tian Tie Technology reported a revenue of 2.136 billion yuan, a 41.69% increase, but the net profit of 15.204 million yuan was largely due to non-recurring gains, masking ongoing core business losses [8][9]. - The company has experienced a continuous cash flow deficit, with a net cash flow from operating activities of -1.4 billion yuan in 2024, indicating deteriorating profitability quality [9][12]. Group 5: Debt and Expansion Plans - The company's debt ratio has increased from 35.95% in 2021 to 56.68% by the first quarter of 2025, nearing the 60% warning line [12]. - Despite financial struggles, the company announced a 1.45 billion yuan investment in a new project, raising concerns about its ability to manage existing debts while pursuing expansion [14][15].